Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2015-03-24 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2014年年度报告
Annual Report Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司 2014 年年度报告全文" which translates to "Cachet Pharmaceutical Co., Ltd. 2014 Annual Report Full Text." It contains detailed financial data, including revenue, net profit, cash flow, and other financial metrics for the fiscal year 2014. The document includes sections such as company overview, accounting data and financial indicators summary, board of directors report, risk disclosures, and detailed financial statements. The presence of comprehensive financial statements and management discussion confirms this is a full annual report rather than a summary or announcement. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2014
2015-03-24 Chinese
2014年企业社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled '2014 年企业社会责任报告' which translates to '2014 Corporate Social Responsibility Report'. It reviews the company's activities and achievements in economic, environmental, and social responsibility for the year 2014. The content includes detailed sections on company overview, business development, management, social responsibility practices, and environmental protection. It follows guidelines from the Shenzhen Stock Exchange for social responsibility reporting. The document is comprehensive, with about 15,000 characters, and contains substantive information on ESG factors and corporate social responsibility initiatives. This matches the definition of an Environmental & Social Information report (ESG report). There is no indication that this is an announcement or a brief summary; it is the full report itself. Therefore, the appropriate classification is Environmental & Social Information (SR).
2015-03-24 Chinese
关于对公司控股股东及其他关联方占用资金情况的专项审计说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the non-operating fund occupation and related party fund transactions of Jia Shi Tang Pharmaceutical Co., Ltd. for the year 2014. It includes an auditor's opinion, references to regulatory requirements from the China Securities Regulatory Commission, and detailed financial tables summarizing related party transactions. The document is titled as a "special audit explanation" and contains audit procedures, responsibilities, and conclusions. It is not a full annual report, earnings release, or management discussion, but a standalone audit report focused on a specific regulatory compliance issue. The document length is 3819 characters, which is sufficient for a detailed audit report but not a brief announcement. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2014
2015-03-24 Chinese
关于召开2014年度股东大会的通知公告
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2014 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司, including the date, time, location, voting procedures (both onsite and online), agenda items to be discussed and voted on, and instructions for shareholders on how to register and vote. It includes the agenda items such as the 2014 annual reports, financial statements, profit distribution plan, and other corporate governance matters. The document also contains an authorization proxy form for shareholders to delegate voting rights. There is no actual financial data or report content included, only the announcement and procedural details for the AGM. The document length is over 6000 characters, which is consistent with a detailed AGM notice. Therefore, this document fits the category of AGM Information (AGM-R) rather than the Annual Report (10-K) or other categories.
2015-03-24 Chinese
关于2014年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2014 annual profit distribution plan by the company 嘉事堂药业股份有限公司. It details the profit figures, dividend distribution plan, and compliance with regulatory guidelines. The document is relatively short (1203 characters) and serves to inform shareholders about the proposed dividend distribution, which will be submitted for approval at the annual general meeting. It does not contain full financial statements or comprehensive financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a Notice of Dividend Amount (DIV) because it is about the profit distribution plan, not the final dividend payment details. The document fits best as a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI), but since it is announcing a profit distribution plan pending shareholder approval, it aligns most closely with a Declaration of Voting Results & Voting Rights Announcements (DVA). However, since the voting has not yet occurred, it is more of a notice about the dividend plan rather than voting results. Given the content and context, the best fit is Notice of Dividend Amount (DIV) because it announces the dividend amount and distribution plan to shareholders, including the amount per share and total dividend payout, which is the primary purpose of DIV filings.
2015-03-24 Chinese
2015年第一次临时股东大会会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2015 first extraordinary shareholders' meeting of 嘉事堂药业股份有限公司. It details the meeting date, attendance, voting methods, and the voting results on various proposals related to the company's non-public stock issuance and related matters. It includes legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official voting results and resolutions passed at the shareholders' meeting, not the meeting materials or presentations themselves. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is about 4977 characters, which is sufficient for a detailed voting results announcement. Therefore, the correct classification is DVA with high confidence.
2015-03-03 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.